When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KURA - Kura's tipifarnib shows positive effect in mid-stage bladder cancer study
Kura Oncology Inc.
Results from an investigator-sponsored Phase 2 clinical trial evaluating Kura Oncology's (KURA+1.9%) tipifarnib in patients with relapsed/refractory HRAS mutation-positive urothelial carcinoma showed a positive effect on progression-free survival (PFS) at month 6.
More news on: Kura Oncology, Inc., Healthcare stocks news, Stocks on the move,